GenIBET Biopharmaceuticals Overview
- Founded
- 2006
- Status
- Private
- Latest Deal Type
- M&A
- Investors
- 1
GenIBET Biopharmaceuticals General Information
Description
Provider of contract manufacturing services which offers comprehensive services that encompasses cell line development, process and analytical development. The company's contract manufacturing services offers specialized microbial, cell culture and viral-process development and current good manufacturing practice (cGMP) services, enabling research groups, biotech and pharma companies to get the opportunity to go from bench to clinic in one facility.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
- Rua Melvin Jones, 1
- Loja C e D
- Oeiras, 2780-133
- Portugal
+351 21 000 0000
GenIBET Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 28-Feb-2019 | Completed | Generating Revenue | |||
| 1. PE Growth/Expansion | Completed | Generating Revenue |
GenIBET Biopharmaceuticals Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Raquel Fortunato Ph.D | Chief Executive Officer |
GenIBET Biopharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Portugal Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |